Waltermire Robert E.

Officer at MDGL

Sold, on record
$11.3M
Dollars the filings state
Form 4 sales
10
Latest Mar 5, 2025
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MDGLMADRIGAL PHARMACEUTICALS, INC.Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MDGLNo plan
    Jan 17, 2025 2025

    Sold 442 shares at $273.41 ($121k)

    Waltermire Robert E., Senior VP, Chief Pharma Dev.

    No 10b5-1 planSold 8% of holdings ($1.5M position)5,058 shares left0.2x usual sizeFollows a Form 144Filing

  2. 2 Form 144 notice MDGLNotice
    Jan 17, 2025 same day

    Filed to sell 442 shares ($121k)

    Waltermire Robert E., Officer

    No 10b5-1 plan0.2x usual sizeFiling

  3. 3 Form 144 notice MDGLNotice
    Jan 24, 2025 +7 days

    Filed to sell 103 shares ($35k)

    Waltermire Robert E., Officer

    No 10b5-1 plan0.1x usual sizeFiling

  4. 4 Form 4 sale MDGLNo plan
    Jan 24, 2025 same day

    Sold 103 shares at $335.24 ($35k)

    Waltermire Robert E., Senior VP, Chief Pharma Dev.

    No 10b5-1 planSold 2% of holdings ($1.7M position)4,955 shares left0.1x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice MDGLNotice
    Feb 28, 2025 +35 days

    Filed to sell 1,227 shares ($418k)

    Waltermire Robert E., Officer

    No 10b5-1 plan0.6x usual sizeFiling

  6. 6 Form 4 sale MDGLNo plan
    Feb 28, 2025 same day

    Sold 1,227 shares at $341.07 ($418k)

    Waltermire Robert E., Senior VP, Chief Pharma Dev.

    No 10b5-1 planSold 24.8% of holdings ($1.7M position)3,728 shares left0.6x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice MDGLNotice
    Mar 5, 2025 +5 days

    Filed to sell 14,113 shares ($4.8M)

    Waltermire Robert E., Officer

    No 10b5-1 plan9x usual sizeFiling

  8. 8 Form 4 sale MDGLUnusual
    Mar 5, 2025 same day

    Sold 14,113 shares at $341.33 ($4.8M)

    Waltermire Robert E., Senior VP, Chief Pharma Dev.

    No 10b5-1 planSold 79.1% of holdings ($6.1M position)3,728 shares left9x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Waltermire Robert E.
Source
Mar 5, 2025Mar 7, 2025MDGLSenior VP, Chief Pharma Dev.Form 4 sale14,113$4.8M79.1%UnusualSEC
Mar 5, 2025Mar 5, 2025MDGLOfficerForm 144 notice14,113$4.8MNoticeSEC
Feb 28, 2025Mar 4, 2025MDGLSenior VP, Chief Pharma Dev.Form 4 sale1,227$418k24.8%No planSEC
Feb 28, 2025Feb 28, 2025MDGLOfficerForm 144 notice1,227$418kNoticeSEC
Jan 24, 2025Jan 27, 2025MDGLSenior VP, Chief Pharma Dev.Form 4 sale103$35k2.0%No planSEC
Jan 24, 2025Jan 24, 2025MDGLOfficerForm 144 notice103$35kNoticeSEC
Jan 17, 2025Jan 17, 2025MDGLOfficerForm 144 notice442$121kNoticeSEC
Jan 17, 2025Jan 17, 2025MDGLSenior VP, Chief Pharma Dev.Form 4 sale442$121k8.0%No planSEC
Jun 14, 2024Jun 18, 2024MDGLSenior VP, Chief Pharma Dev.Form 4 sale1,900$532k25.7%UnusualSEC
Jun 14, 2024Jun 14, 2024MDGLOfficerForm 144 notice1,900$532kNoticeSEC
Jun 12, 2024Jun 14, 2024MDGLSenior VP, Chief Pharma Dev.Form 4 sale2,000$570k26.7%UnusualSEC
Jun 12, 2024Jun 12, 2024MDGLOfficerForm 144 notice6,000$1.7MNoticeSEC
May 21, 2024May 23, 2024MDGLSenior VP, Chief Pharma Dev.Form 4 sale1,036$240k15.9%No planSEC
Dec 15, 2023Dec 18, 2023MDGLSenior VP, Chief Pharma Dev.Form 4 sale4,000$942k41.4%UnusualSEC
Dec 13, 2023Dec 14, 2023MDGLSenior VP, Chief Pharma Dev.Form 4 sale3,800$847k40.1%UnusualSEC
Mar 1, 2023Mar 2, 2023MDGLSenior VP, Chief Pharma Dev.Form 4 sale10,000$2.7M63.8%UnusualSEC